Presentation on theme: "AstraZeneca in Algeria Driven by Science, Serving Patients"— Presentation transcript:
1 AstraZeneca in Algeria Driven by Science, Serving Patients Habib BennaceurNorth West Africa President10th December 2014
2 AstraZeneca is present in Algeria since 2006 AstraZeneca in Algeria - We push the boundaries of science to deliver life-changing medicinesAstraZeneca is present in Algeria since 2006170 employees AstraZeneca provides Algerian patients with multiple important molecules, particularly in Oncology, Cardiovascular, Respiratory and Gastrointestinal.
3 AstraZeneca as an active partner in developing people in Algeria: Our priorities Patient support educationR&D capabilitiesLocal manufacturing and technology transferHealth Care Professional skillsAstraZeneca Algeria as best place to work
4 AstraZeneca Algeria at a Glance : Opportunities and Challenges LanguageInternational experienceTurnoverYoung populationDiversityEducationeconomical and political stabilityLong term presenceScarcity & competition for talents with rising manpower costs to attract &retain the bestLack of International experienceNew people managers mainly, internally promoted
5 AstraZeneca Algeria long term commitment Ministry of HealthMedical Scientific SocietiesPatient AssociationsPublic HealthPatient First- Patient support program- Patient educators for chronic diseasesPartneringFor Scientific Leadership- R&D (ATLANTIC, ESMAA).- CME- Partnerships with International academiesEmployeesGreat Place to WorkWe engage and inspire AstraZeneca employees about our commitment to addressing urgent public health threatsJVAZ Algeria industrial Foot PrintToll manufacturingCollaboration with SAIDAL
6 AZ Algeria Oncology plan - Five pillars Supporting Algerian Government Strategy Assessment of Cancer centers and send recommendation to reach international standardsHave 1 or 2 centers accredited by Karolinska or Gustavo RoussyNational cancer registries implementationSupport R&DImplement strong screening program for Breast/Prostatic/ Colon cancerWork on “Phakamisa” modelKc screening andpreventionValidate EGFR Plateform by Karolinska centerExpand diagnosis capabilities to other mutations typeDevelop “Microbiologists” capabilitiesEnhance DiagnosisplateformAssess GPs role in prevention/Screening/Follow up of the patientsSupport GPs training in OncologyWork on “Oncology Network” developmentBuild HCP Network & training*based on data presented at January 2014 JP Morgan Conference.Provide Nurses and Psychologists at home for palliative treatmentsPatient support program
7 Algeria - Headquarter for North West African countries TinisiaMorocoWesterne SaharaMauritaniaSenegalGambiaMaliGuiniaCote d’IvoireChadCent- African-RpCameroomDemoc-Rp- CongoCongoGabonNigerBeninTogo